Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of Breast Cancer
>
2011
>
14
>
3
Volume:
14
Issue:
3
1. Clinical Outcome of Magnetic Resonance Imaging-Detected Additional Lesions in Breast Cancer Patients.
Page:213—218
2. The Prognostic Significance of the Lymph Node Ratio in Axillary Lymph Node Positive Breast Cancer.
Page:204—212
3. The Role of Lymphovascular Invasion as a Prognostic Factor in Patients with Lymph Node-Positive Operable Invasive Breast Cancer.
Page:198—203
4. The Impact of Local and Regional Recurrence on Distant Metastasis and Survival in Patients Treated with Breast Conservation Therapy.
Page:191—197
5. G-protein Coupled Estrogen Receptor 1 Expression in Primary Breast Cancers and Its Correlation with Clinicopathological Variables.
Page:185—190
6. Vascular Endothelial Growth Factor Levels in Relation to Oxidative Damage and Antioxidant Status in Patients with Breast Cancer.
Page:181—184
7. Can CD44+/CD24- Tumor Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy?.
Page:175—180
8. Heat Shock Protein as Molecular Targets for Breast Cancer Therapeutics.
Page:167—174
9. Invited Commentary on: Can CD44+/CD24- Tumor Stem Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy?.
Page:251—252
10. Invasive Lobular Breast Cancer Presenting an Unusual Metastatic Pattern in the Form of Peritoneal and Rectal Metastases: A Case Report.
Page:247—250
11. Undifferentiated Pleomorphic Sarcoma of the Male Breast Causing Diagnostic Challenges.
Page:241—246
12. Borderline Phyllodes Tumor with an Incidental Invasive Tubular Carcinoma and Lobular Carcinoma In Situ Component: A Case Report.
Page:237—240
13. Nation-Wide Korean Breast Cancer Data from 2008 Using the Breast Cancer Registration Program.
Page:229—236
14. Comparison of CVF (Cyclophosphamide+Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide+Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer.
Page:223—228
15. The Evaluation of Contralateral Breast Lesions in Breast Cancer Patients Using Reduction Mammoplasty.
Page:219—222